Journal Article: Reassessing the putative molecular Target(s) of potent antitubercular 2-(Alkylsulfonyl)acetamides
Farr, Dylan C., Haselhorst, Thomas, Tan, Lendl, Furness, Juanelle, Strong, Emily, Grice, I. Darren, West, Nicholas P. and Houston, Todd A. (2024). Reassessing the putative molecular Target(s) of potent antitubercular 2-(Alkylsulfonyl)acetamides. European Journal of Medicinal Chemistry, 264 115983, 1-12. doi: 10.1016/j.ejmech.2023.115983
Conference Publication: Macrophage plasticity and activation states drive differential expression of murine macrophage galactose-type lectin (MGL) orthologs
Paez, Reina N., Browning, Sarah, Files, Megan A., Varghese, Alyssa A., Huante, Matthew B., Strong, Emily, Lee, Sunhee, Endsley, Mark A. and Endsley, Janice J. (2023). Macrophage plasticity and activation states drive differential expression of murine macrophage galactose-type lectin (MGL) orthologs. Annual Meeting of the American Association of Immunologists (AAI), Washington, DC United States, 11-15 May 2023. Rockville, MD United States: American Association of Immunologists. doi: 10.4049/jimmunol.210.Supp.160.32
Journal Article: FDA-approved amoxapine effectively promotes macrophage control of mycobacteria by inducing autophagy
Wang, Jia, Sha, Jian, Strong, Emily, Chopra, Ashok K. and Lee, Sunhee (2022). FDA-approved amoxapine effectively promotes macrophage control of mycobacteria by inducing autophagy. Microbiology Spectrum, 10 (5). doi: 10.1128/spectrum.02509-22
A Faster Cure for Tuberculosis: Revealing Adjunctive Antimicrobial Solutions
(2023–2027) NHMRC IDEAS Grants
Reassessing the putative molecular Target(s) of potent antitubercular 2-(Alkylsulfonyl)acetamides
Farr, Dylan C., Haselhorst, Thomas, Tan, Lendl, Furness, Juanelle, Strong, Emily, Grice, I. Darren, West, Nicholas P. and Houston, Todd A. (2024). Reassessing the putative molecular Target(s) of potent antitubercular 2-(Alkylsulfonyl)acetamides. European Journal of Medicinal Chemistry, 264 115983, 1-12. doi: 10.1016/j.ejmech.2023.115983
FDA-approved amoxapine effectively promotes macrophage control of mycobacteria by inducing autophagy
Wang, Jia, Sha, Jian, Strong, Emily, Chopra, Ashok K. and Lee, Sunhee (2022). FDA-approved amoxapine effectively promotes macrophage control of mycobacteria by inducing autophagy. Microbiology Spectrum, 10 (5). doi: 10.1128/spectrum.02509-22
Reversing BCG-mediated autophagy inhibition and mycobacterial survival to improve vaccine efficacy
Gonzalez-Orozco, Maria, Strong, Emily J., Paroha, Ruchi and Lee, Sunhee (2022). Reversing BCG-mediated autophagy inhibition and mycobacterial survival to improve vaccine efficacy. BMC Immunology, 23 (1) 43. doi: 10.1186/s12865-022-00518-z
Strong, Emily J., Wang, Jia, Ng, Tony W., Porcelli, Steven A. and Lee, Sunhee (2022). Mycobacterium tuberculosis PPE51 inhibits autophagy by suppressing toll-like receptor 2-dependent signaling. MBio, 13 (3). doi: 10.1128/mbio.02974-21
Strong, Emily, Hart, Bryan, Wang, Jia, Orozco, Maria Gonzalez and Lee, Sunhee (2022). Induced synthesis of mycolactone restores the pathogenesis of Mycobacterium ulcerans in vitro and in vivo. Frontiers in Immunology, 13 750643. doi: 10.3389/fimmu.2022.750643
Strong, Emily J., Ng, Tony W., Porcelli, Steven A. and Lee, Sunhee (2021). Mycobacterium tuberculosis PE_PGRS20 and PE_PGRS47 proteins inhibit autophagy by interaction with Rab1A. Msphere, 6 (4), 1-17. doi: 10.1128/msphere.00549-21
Strong, Emily J. and Lee, Sunhee (2021). Targeting autophagy as a strategy for developing new vaccines and host-directed therapeutics against mycobacteria. Frontiers in Microbiology, 11 614313. doi: 10.3389/fmicb.2020.614313
Strong, Emily J., Jurcic Smith, Kristen L., Saini, Neeraj K., Ng, Tony W., Porcelli, Steven A. and Lee, Sunhee (2020). Identification of autophagy-inhibiting factors of mycobacterium tuberculosis by high-throughput loss-of-function screening. Infection and Immunity, 88 (12) e00269-20. doi: 10.1128/IAI.00269-20
Tan, Lendl, Strong, Emily J., Woods, Kyra and West, Nicholas P. (2018). Homologous alignment cloning: a rapid, flexible and highly efficient general molecular cloning method. PeerJ, 6 (6) e5146, e5146. doi: 10.7717/peerj.5146
Use of soluble extracellular regions of MmpL (SERoM) as vaccines for tuberculosis
Strong, Emily J. and West, Nicholas P. (2018). Use of soluble extracellular regions of MmpL (SERoM) as vaccines for tuberculosis. Scientific Reports, 8 (1) 5604, 5604. doi: 10.1038/s41598-018-23893-3
Dando, Samantha J., Ipe, Deepak S., Batzloff, Michael, Sullivan, Matthew J., Crossman, David K., Crowley, Michael, Strong, Emily, Kyan, Stephanie, Leclercq, Sophie Y., Ekberg, Jenny A. K., St John, James, Beacham, Ifor R. and Ulett, Glen C. (2016). Burkholderia pseudomallei capsule exacerbates respiratory melioidosis but does not afford protection against antimicrobial signaling or bacterial killing in human olfactory ensheathing cells. Infection and Immunity, 84 (7), 1941-1956. doi: 10.1128/IAI.01546-15
Paez, Reina N., Browning, Sarah, Files, Megan A., Varghese, Alyssa A., Huante, Matthew B., Strong, Emily, Lee, Sunhee, Endsley, Mark A. and Endsley, Janice J. (2023). Macrophage plasticity and activation states drive differential expression of murine macrophage galactose-type lectin (MGL) orthologs. Annual Meeting of the American Association of Immunologists (AAI), Washington, DC United States, 11-15 May 2023. Rockville, MD United States: American Association of Immunologists. doi: 10.4049/jimmunol.210.Supp.160.32
Strong, Emily (2017). A Functional Genomics Approach to Vaccine Development Against Mycobacterium tuberculosis and the Role MmpL13 Plays in Tuberculosis Infection. PhD Thesis, School of Chemistry & Molecular Biosciences, The University of Queensland. doi: 10.14264/uql.2017.1037
A Faster Cure for Tuberculosis: Revealing Adjunctive Antimicrobial Solutions
(2023–2027) NHMRC IDEAS Grants